Abstract
Purpose of Review
In this review, we discuss the evidence for the use of liposome bupivacaine during the perioperative period when used for surgical site infiltration or as part of a peripheral/epidural nerve block.
Recent Findings
There is sparse high-quality evidence from randomized controlled trials that liposome bupivacaine is superior to traditional bupivacaine when surgically infiltrated. The evidence for liposome bupivacaine used as part of peripheral and epidural nerve blocks is promising, but its superiority is yet to be determined when compared to single-injection or continuous perineural infusions using unencapsulated (standard) long-acting local anesthetics.
Summary
High-quality, adequately powered, prospective, randomized, controlled trials are still needed to adequately compare liposome bupivacaine to unencapsulated local anesthetic for peripheral nerve blocks and surgical site infiltration.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Golf M, Daniels SE, Onel E. A phase 3, randomized, placebo-controlled trial of DepoFoam(R) bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. 2011;28(9):776–88.
Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2011;54(12):1552–9.
• Hadzic A, Minkowitz HS, Melson TI, Berkowitz R, Uskova A, Ringold F, et al. Liposome bupivacaine femoral nerve block for postsurgical analgesia after total knee arthroplasty. Anesthesiology. 2016;124(6):1372–83. This is a well-designed clinical trial demonstrating the efficacy of liposomal bupivacaine for femoral nerve blocks when compared to placebo.
Ilfeld BM, Malhotra N, Furnish TJ, Donohue MC, Madison SJ. Liposomal bupivacaine as a single-injection peripheral nerve block: a dose-response study. Anesth Analg. 2013;117(5):1248–56.
Sessler DI, Imrey PB. Clinical research methodology 1: study designs and methodologic sources of error. Anesth Analg. 2015;121(4):1034–42.
Nadeau MH, Saraswat A, Vasko A, Elliott JO, Vasko SD. Bupivacaine versus liposomal bupivacaine for postoperative pain control after augmentation mammaplasty: a prospective, randomized, double-blind trial. Aesthet Surg J. 2016;36(2):NP47–52.
Smoot JD, Bergese SD, Onel E, Williams HT, Hedden W. The efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammaplasty: a randomized, double-blind, active-control study. Aesthet Surg J. 2012;32(1):69–76.
Bergese SD, Ramamoorthy S, Patou G, Bramlett K, Gorfine SR, Candiotti KA. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res. 2012;5:107.
Haas E, Onel E, Miller H, Ragupathi M, White PF. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg. 2012;78(5):574.
Langford RM, Chappell GM, Karrasch JA. A single administration of DepoBupivacaine intraoperatively results in prolonged detectable plasma bupivacaine and analgesia in patients undergoing inguinal hernia repair [Abstract P-9088]. Presented at the Annual Postgraduate Assembly in Anesthesiology of the New York State Society of Anesthesiologists, 2008.
White PF, Schooley GL, Ardeleanu M. Analgesia following a single administration of depobupivacaine intraoperatively in patients undergoing inguinal herniorrhaphy: preliminary dose-ranging studies [abstract S-242]. Anesth Analg 2009;108(Suppl 3S):S-242.
• Yeung J, Crisp CC, Mazloomdoost D, Kleeman SD, Pauls RN. Liposomal bupivacaine during robotic colpopexy and posterior repair: a randomized controlled trial. Obstet Gynecol. 2018;131(1):39–46. A recent trial studying the efficacy of liposome bupivacaine for robotic surgery.
Knight RB, Walker PW, Keegan KA, Overholser SM, Baumgartner TS, Ebertowski JS 2nd, et al. A randomized controlled trial for pain control in laparoscopic urologic surgery: 0.25% bupivacaine versus long-acting liposomal bupivacaine. J Endourol. 2015;29(9):1019–24.
Gatherwright J, Knackstedt RW, Ghaznavi AM, Bernard S, Schwarz G, Moreira A, et al. Prospective, randomized, controlled comparison of bupivacaine versus liposomal bupivacaine for pain management after unilateral delayed deep inferior epigastric perforator free flap reconstruction. Plast Reconstr Surg. 2018;141(6):1327–30.
• Ilfeld BM, Gabriel RA, Eisenach JC. Liposomal bupivacaine infiltration for knee arthroplasty: significant analgesic benefits or just a bunch of fat? Anesthesiology. 2018;129(4):623–6. A good review/editorial on the evidence for liposome bupivacaine in surgical site infiltration for total knee arthroplasty.
Snyder MA, Scheuerman CM, Gregg JL, Ruhnke CJ, Eten K. Improving total knee arthroplasty perioperative pain management using a periarticular injection with bupivacaine liposomal suspension. Arthroplast Today. 2016;2(1):37–42.
•• Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplast. 2018;33(1):90–6. a clinical trial demonstrating the efficacy of liposome bupivacaine for surgical site infiltration following total knee arthroplasty
•• Shafer SL. Letter to the Editor on “Local Infiltration Analgesia With Liposomal Bupivacaine Improves Pain Scores and Reduces Opioid Use After Total Knee Arthroplasty: Results of a Randomized Controlled Trial”. J Arthroplast. 2018;33(8):2694. An important editorial highlighting the weaknesses of the PILLAR trial.
Surdam JW, Licini DJ, Baynes NT, Arce BR. The use of Exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. J Arthro 2015;30:325–9.
Okoroha KR, Keller RA, Marshall NE, Jung EK, Mehran N, Owashi E, et al. Liposomal bupivacaine versus femoral nerve block for pain control after anterior cruciate ligament reconstruction: a prospective randomized trial. Arthroscopy. 2016;32(9):1838–45.
Okoroha KR, Lynch JR, Keller RA, Korona J, Amato C, Rill B, et al. Liposomal bupivacaine versus interscalene nerve block for pain control after shoulder arthroplasty: a prospective randomized trial. J Shoulder Elb Surg. 2016;25(11):1742–8.
Namdari S, Nicholson T, Abboud J, Lazarus M, Steinberg D, Williams G. Randomized controlled trial of interscalene block compared with injectable liposomal bupivacaine in shoulder arthroplasty. J Bone Joint Surg Am. 2017;99(7):550–6.
Abildgaard JT, Lonergan KT, Tolan SJ, Kissenberth MJ, Hawkins RJ, Washburn R 3rd, et al. Liposomal bupivacaine versus indwelling interscalene nerve block for postoperative pain control in shoulder arthroplasty: a prospective randomized controlled trial. J Shoulder Elb Surg. 2017;26(7):1175–81.
Amundson AW, Johnson RL, Abdel MP, Mantilla CB, Panchamia JK, Taunton MJ, et al. A three-arm randomized clinical trial comparing continuous femoral plus single-injection sciatic peripheral nerve blocks versus periarticular injection with ropivacaine or liposomal bupivacaine for patients undergoing total knee arthroplasty. Anesthesiology. 2017;126(6):1139–50.
• Sabesan VJ, Shahriar R, Petersen-Fitts GR, Whaley JD, Bou-Akl T, Sweet M, et al. A prospective randomized controlled trial to identify the optimal postoperative pain management in shoulder arthroplasty: liposomal bupivacaine versus continuous interscalene catheter. J Shoulder Elb Surg. 2017;26(10):1810–7. One of few clinical trials demonstrating the benefits of liposome bupivacaine when used for interscalene nerve blocks
Corman S, Shah N, Dagenais S. Medication, equipment, and supply costs for common interventions providing extended post-surgical analgesia following total knee arthroplasty in US hospitals. J Med Econ. 2018;21(1):11–8.
Hutchins J, Delaney D, Vogel RI, Ghebre RG, Downs LS Jr, Carson L, et al. Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: a prospective randomized controlled study. Gynecol Oncol. 2015;138(3):609–13.
Hutchins JL, Kesha R, Blanco F, Dunn T, Hochhalter R. Ultrasound-guided subcostal transversus abdominis plane blocks with liposomal bupivacaine vs. non-liposomal bupivacaine for postoperative pain control after laparoscopic hand-assisted donor nephrectomy: a prospective randomised observer-blinded study. Anaesthesia. 2016;71(8):930–7.
Vandepitte C, Kuroda M, Witvrouw R, Anne L, Bellemans J, Corten K, et al. Addition of liposome bupivacaine to bupivacaine HCl versus bupivacaine HCl alone for interscalene brachial plexus block in patients having major shoulder surgery. Reg Anesth Pain Med. 2017;42(3):334–41.
Viscusi ER, Candiotti KA, Onel E, Morren M, Ludbrook GL. The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers. Reg Anesth Pain Med. 2012;37(6):616–22.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Rodney A. Gabriel’s institution has received funding and product for his research from Myoscience and Epimed; infusion pump manufacturer InfuTronix; perineural catheter manufacturer Ferrosan Medical; and a manufacturer of a peripheral nerve stimulation device, SPR Therapeutics. Brian M. Ilfeld’s institution has received funding and product for his research from Myoscience and Epimed; infusion pump manufacturer InfuTronix; perineural catheter manufacturer Ferrosan Medical; a manufacturer of a peripheral nerve stimulation device, SPR Therapeutics; and, a manufacturer of a long-acting bupivacaine formulation, Heron Pharmaceuticals.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Regional Anesthesia
Rights and permissions
About this article
Cite this article
Gabriel, R.A., Ilfeld, B.M. An Updated Review on Liposome Bupivacaine. Curr Anesthesiol Rep 9, 321–325 (2019). https://doi.org/10.1007/s40140-019-00327-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40140-019-00327-y